The effects of Nocturnal Haemodialysis (NHD) compared to conventional haemodialysis on progression of Left Ventricular (LV) mass: a randomised controlled pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN25858715

Enrollment

Registered

2004-10-19

Start date

2004-08-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage kidney disease Urological and Genital Diseases Renal disease

Interventions

Subjects are randomised to nocturnal haemodialysis or conventional three times per week haemodialysis (controls).

Eligibility

Inclusion criteria

Inclusion criteria: All adult haemodialysis patients in Alberta, Canada are eligible.

Exclusion criteria

Exclusion criteria: Patients who are unable to perform NHD due to physical or mental incapacity.

Design outcomes

Primary

Measure	Time frame
Change in left ventricular mass (measured by CMR) at 6 months.	—

Secondary

Measure	Time frame
1. Mean change in systolic Blood Pressure (BP) 2. Change in HRQOL (Health-Related Quality-Of-Life) 3. Mean change in Haematocrit (Hct)/Erythropoietin (Epo) ratio 4. Mean change in calcium - phosphorus product	—

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 6, 2026